FEBUXOSTAT VIATRIS 80 MG TBL FLM 84 KAL II

What is the maximum co-payment for FEBUXOSTAT VIATRIS?

If the insurance company contributes, the maximum co-payment is 710,14 Kč. The maximum pharmacy price is 1 587,22 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but the reimbursement conditions (reporting limit) have not been set.

Does FEBUXOSTAT VIATRIS have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

877,08 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Febuxostat je hrazen v léčbě chronické hyperurikémie u pacientů, u nichž je alopurinol kontraindikován nebo intolerován, a to z důvodů řádně uvedených v klinické dokumentaci, nebo u pacientů, u nichž není maximální tolerovanou dávkou alopurinolu dosaženo hodnoty kyseliny močové 360 mikromol/l nebo nižší. Pokud je v průběhu dvou po sobě následujících kontrolních vyšetření zjištěno, že hladina urikémie po zahájení léčby febuxostatem neklesá, léčba febuxostatem není nadále hrazena z veřejného zdravotního pojištění.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe FEBUXOSTAT VIATRIS?

Prescription is not conditional on a medical specialization.

What is the composition of FEBUXOSTAT VIATRIS?

Febuxostat (80 mg), laktosa, neznámá látka s kódem 3755, magnesium-stearát, neznámá látka s kódem 4336, sodná sůl kroskarmelosy, neznámá látka s kódem 13317, koloidní bezvodý oxid křemičitý, neznámá látka s kódem 4987, ointmentek, hypromelosa, oxid titaničitý, neznámá látka s kódem 4065, žlutý oxid železitý, neznámá látka s kódem 4105, černý oxid železitý. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to FEBUXOSTAT VIATRIS?

The medicine belongs to ATC group M04AA03 – FEBUXOSTAT. Medicines with the same active substance can be found here.

Who manufactures FEBUXOSTAT VIATRIS?

VIATRIS LIMITED, Dublin (IRL)

Is the medicine in shortage?

The latest report from the manufacturer is from 5. 6. 2024. Production was interrupted as of 5. 8. 2024. The stated reason was: Výrobní důvody.
Resumption of supply is expected 30. 6. 2026
The manufacturer lists medicines with the following code as a potential substitute: